Premium Nahrungsergänzungsmittel | artgerecht

Pridinol Mesilate: Muscle Relaxant for Spasms

Pridinol mesilate is a muscle relaxant used to treat painful muscle spasms and tension. It acts both centrally and peripherally to effectively reduce elevated muscle tone.

Regular tips about health Regular tips about health

Things worth knowing about "Pridinol Mesilate"

Pridinol mesilate is a muscle relaxant used to treat painful muscle spasms and tension. It acts both centrally and peripherally to effectively reduce elevated muscle tone.

What is Pridinol Mesilate?

Pridinol mesilate is a muscle relaxant (myotonolytic agent) used in the treatment of painful muscle spasms and tension. It belongs to the group of centrally and peripherally acting muscle relaxants and is commonly prescribed for acute and chronic musculoskeletal conditions involving increased muscle tone.

Indications

Pridinol mesilate is typically indicated for:

Painful muscle spasms and tension in the spinal region (e.g., back pain, neck stiffness)
Muscle hypertonia associated with orthopaedic or neurological conditions
Post-traumatic muscle tension following injury or surgery
Torticollis (wry neck) and related conditions with elevated muscle tone

Mechanism of Action

Pridinol mesilate exerts its therapeutic effects through several mechanisms:

Anticholinergic action: It inhibits the neurotransmitter acetylcholine at muscarinic receptors, contributing to relaxation of both smooth and striated muscle.
Central action: Pridinol exerts a dampening effect on areas of the central nervous system (CNS) involved in regulating muscle tone, particularly polysynaptic reflex arcs in the spinal cord.
Peripheral action: In addition, it influences neuromuscular transmission at the motor end plate, directly reducing muscle excitability.

Dosage and Administration

The dosage of pridinol mesilate depends on the severity of symptoms and the individual response of the patient. Typical dosing recommendations include:

Oral (tablets): Generally 2 to 4 mg of pridinol mesilate two to three times daily. The exact dose should always be determined by the treating physician.
Intramuscular or intravenous: In acute cases, pridinol mesilate may be administered by injection, with dosage adjusted under medical supervision.

The medication should not be discontinued abruptly. Treatment duration is generally limited to the acute phase of symptoms and should be monitored by a healthcare professional.

Side Effects

Like all medications, pridinol mesilate can cause side effects, most of which are related to its anticholinergic properties:

Dry mouth
Visual disturbances (accommodation disorders)
Dizziness and drowsiness
Increased heart rate (tachycardia)
Constipation
Urinary retention (difficulty urinating)
In rare cases: confusion or agitation, particularly in elderly patients

Contraindications

Pridinol mesilate must not be used in patients with:

Known hypersensitivity to pridinol or any of the excipients
Narrow-angle glaucoma
Benign prostatic hyperplasia with urinary retention
Myasthenia gravis (a neuromuscular disorder causing muscle weakness)
Pregnancy and breastfeeding (due to insufficient safety data)

Drug Interactions

Pridinol mesilate may interact with other medications:

Other anticholinergic agents: Enhanced anticholinergic side effects (e.g., with antihistamines, tricyclic antidepressants)
Alcohol and CNS depressants: Increased sedative effect
Dopamine antagonists: Potential mutual reduction of therapeutic effects

Treatment Context

Pridinol mesilate is frequently used as part of a comprehensive treatment approach for muscle tension and spasm. In addition to medication, complementary measures such as physiotherapy, heat application, and targeted exercises to improve muscle flexibility and posture are recommended. Patients should avoid driving or operating heavy machinery during treatment, as the medication may impair reaction time and alertness.

References

Mutschler, E. et al. - Drug Effects: Textbook of Pharmacology, Clinical Pharmacology and Toxicology. 10th Edition. Wissenschaftliche Verlagsgesellschaft Stuttgart, 2013.
European Medicines Agency (EMA) - Assessment Reports and Product Information for Muscle Relaxants. Available at: https://www.ema.europa.eu
Lullmann, H., Mohr, K., Hein, L. - Pharmacology and Toxicology. 17th Edition. Thieme Verlag, 2010.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.